Using pathophysiologic studies of clinical samples and molecular studies in cell lines, we have established a novel and potentially important function forTET2-mediated DNA hydroxymethylation in negatively regulating PRAME expression in melanoma. This evidence concerns the gene PRAME and melanoma.